The Global Natriuretic Peptide Market is estimated to grow at a significant CAGR during the forecast period. The heart produces peptides called natriuretic peptides. BNP (brain natriuretic peptide) and N-terminal pro-b-type natriuretic peptide (N-terminal pro-b-type natriuretic peptide) are the two primary forms of these chemicals (NT-proBNP). BNP and NT-proBNP are normally detected in trace amounts in the bloodstream. High amounts could indicate that your heart isn’t pumping as much blood as it should. Heart failure, also known as congestive heart failure, occurs when this happens. BNP or NT-proBNP levels in the blood are measured by natriuretic peptide analyses. The doctor may request either a BNP or an NT-proBNP test, but not both. They’re both useful for identifying heart failure, but they employ distinct measurements. The equipment available in your provider’s suggested laboratory will determine your selection.
A full report of Natriuretic Peptide Market is available at: https://www.omrglobal.com/industry-reports/natriuretic-peptide-market
The market is predicted to expand during the forecast period, owing to major influencing factors such as the rising prevalence of heart disorders, an increase in the geriatric population, improved knowledge of healthcare and diagnostic technologies, sophisticated nature of the test, and growing demand for effective cardiac disease diagnostic tests. Furthermore, increased funding for cardiac biomarker research from both public and private institutions is likely to support market growth in the coming years.
To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/natriuretic-peptide-market
According to WHO, an estimated 17.9 million people died from CVDs in 2019, representing 32% of all global deaths. Of these deaths, 85% were due to heart attack and stroke. BNP testing is an important diagnostic tool for the diagnosis of cardiovascular disorders. BNP testing is primarily used to diagnose cardiovascular disorders such as cardiac arrest and cardiac failure. In general, a high BNP level (more than 100 pg/ml) implies the presence of signs of chronic cardiac disease, such as heart failure.
Market Coverage
- The market number available for – 2020-2027
- Base year- 2020
- Forecast period- 2021-2027
- Segments Covered
o By Product
o By End-User
- Regions Covered
o North America
o Europe
o Asia-Pacific
o Rest of the world
- Competitive Landscape: Raybiotech, Aviva Systems Biology, AssayPro, Biomatik, Novus Biologicals among others.
Key questions addressed by the report
- What is the market growth rate?
- Which segment and region dominates the market in base year?
- Which segment and region will project fastest growth in the market?
- How COVID-19 impacted the market?
o Recovery Timeline
o Deviation from pre-COVID forecast
o Most affected region and segment
- Who is the leader in the market?
- How players are addressing challenges to sustain growth?
- Where is the investment opportunity?
Global Natriuretic Peptide Market by Segments
By Product
- 0.1-1000 pg/ml
- 0.31-20 ng/ml
By End-User
- Medical Care
- Others
Company Profiles
- Raybiotech
- Aviva Systems Biology
- AssayPro
- Biomatik
- Novus Biologicals
This release has been published on OMR Industry Journal. OMR Industry Journal is not responsible for any content included in this release.
